An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, March 19th at 4:30 PM EST for a presentation by Dr. Paul Gaglio of Columbia University College of Physicians and Surgeons. Dr. Gaglio will present on:
“Controversies in HCV Therapy”
Dr. Gaglio is Professor of Medicine at the Columbia University Medical Center, and the director of Hepatology Outreach. He graduated from the University of Medicine and Dentistry of New Jersey (UMDNJ) and completed his residency in internal medicine at The Mount Sinai Medical Center in NY. His research interests include: the therapy of viral hepatitis, liver failure, and fatty liver disease. He is a member of multiple professional organizations, such as the New York Consortium for Liver Transplantation for which he has sat on the Board of Directors and president of the Board. Dr. Gaglio received the Surgical Housestaff Teaching Award from Tulane University in 2001. He has been consistently listed in such compendia as Best Doctors in America, Castle Connelly Top Doctors in New York, and Who’s Who in America.
On Tuesday, March 12th, Andrew Reynolds presented on: “An Overview of Non-Injection Drug Use and Hepatitis C”
Andrew Reynolds is a Hepatitis C and Harm Reduction Consultant. In this role, he provides technical assistance, training and capacity-building, as well as writes health education materials, fact sheets, toolkits and articles on all aspects of hepatitis C awareness, prevention and treatment, and he has extensive experience in viral hepatitis and drug user health policy. He is the author of the Positively Aware “Annual Hepatitis C Drug Guide,” and sits on the AASLD/IDSA HCV Guidance Panel. Andrew has over 20 years of HCV, HIV and STD awareness, prevention and treatment experience, delivered in a wide variety of settings from street outreach to clinical settings to jails and prisons. In addition to HCV, Andrew works extensively in drug user health, harm reduction and safe consumption space education and advocacy. He serves on numerous boards of directors, advisory boards and committees, including the Organizing Committee of the “End the Epidemics” campaign for California, a community initiative to eliminate HIV, HCV and STDs in California.
Access the slides here
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.